Główka Franciszek K, Karaźniewicz Marta
Department of Physical Pharmacy and Pharmacokinetics, University of Medical Sciences, 6, Swiecickiego Street, 60-781 Poznań, Poland.
J Pharm Biomed Anal. 2004 Jun 29;35(4):807-16. doi: 10.1016/j.jpba.2004.01.030.
A stereospecific capillary zone electrophoresis (CZE) method for determination of the enantiomers of some 2-arylpropionic acid derivatives (2-APA, profens) in human serum has been developed. Racemic-ibuprofen (rac-IBP), racemic-flurbiprofen (rac-FBP), racemic-ketoprofen (rac-KTP) and (+)-S-naproxen ((+)-S-NPX--an internal standard) were chosen for these studies. The 2-APA enantiomers were extracted from acidified serum samples using methylene chloride separated in a fused silica capillary. The capillary was filled with a background electrolyte, which consisted of 0.05 M heptakis 2,3,6-tri-O-methyl-beta-cyclodextrin (TMbetaCD) (chiral selector) in 0.02 M triethanolamine-phosphate buffer of pH 5.0. Separation and resolution of the enantiomer mixture were obtained in one analytical run. The calculated electrophoretic parameters of the analytes were as follows: electrophoretic mobility, micorep(-)-R = -0.75 x 10(-4) to -0.30 x 10(-4) cm2/Vs; micorep(+)-S = -0.83 -(-0.38) cm2/Vs and electroosmotic mobility, microEOF = 2.35 x 10(-4) cm2/Vs, migration times, tmigr R = 12.55 - 16.07 min; tmigr s = 13.08 - 16.9 min, resolution factors, RS = 1.88 - 3.70 and chiral selectivity, alpha = 1.16 - 1.34. The method developed for the enantiomers was validated. The calibration curves were linear in the range of 0.5-50.0 microg/ml for FBP or KTP and of 1.0-50.0 microg/ml for IBP enantiomer concentrations. Recovery of the enantiomers from serum was about 90%. At the limit of quantification (LOQ) precision and accuracy were within 15%. The validated method was successfully applied to pharmacokinetic and bioavailability studies on KTP enantiomers in humans after administration of standard and sustained release tablets of rac-KTP. Significant differences in the pharmacokinetic parameters of both formulations were observed and the studied formulations were not bioequivalent.
已开发出一种立体特异性毛细管区带电泳(CZE)方法,用于测定人血清中某些2-芳基丙酸衍生物(2-APA,洛芬类药物)的对映体。选择消旋布洛芬(rac-IBP)、消旋氟比洛芬(rac-FBP)、消旋酮洛芬(rac-KTP)和(+)-S-萘普生((+)-S-NPX——一种内标)用于这些研究。使用二氯甲烷从酸化的血清样品中提取2-APA对映体,在熔融石英毛细管中进行分离。毛细管中填充有背景电解质,其由0.05 M七(2,3,6-三-O-甲基-β-环糊精)(TMβCD)(手性选择剂)溶解于pH 5.0的0.02 M三乙醇胺-磷酸盐缓冲液中组成。对映体混合物在一次分析运行中即可实现分离和拆分。计算得到的分析物电泳参数如下:电泳迁移率,μrep(-)-R = -0.75×10^(-4)至-0.30×10^(-4) cm²/Vs;μrep(+)-S = -0.83 - (-0.38) cm²/Vs,电渗迁移率,μEOF = 2.35×10^(-4) cm²/Vs,迁移时间,tmigr R = 12.55 - 16.07分钟;tmigr s = 13.08 - 16.9分钟,分离度因子,RS = 1.88 - 3.70,手性选择性,α = 1.16 - 1.34。所开发的对映体分析方法经过了验证。对于FBP或KTP,校准曲线在0.5 - 50.0 μg/ml范围内呈线性,对于IBP对映体浓度,校准曲线在1.0 - 50.0 μg/ml范围内呈线性。对映体从血清中的回收率约为90%。在定量限(LOQ)处,精密度和准确度在15%以内。经验证的方法成功应用于消旋KTP标准片和缓释片给药后人KTP对映体的药代动力学和生物利用度研究。观察到两种制剂的药代动力学参数存在显著差异,且所研究的制剂不具有生物等效性。